Komori
GNI Group (2160) · InitiativeFirst stated

Focus on rare diseases and use of the Fast Track designation

First written in FY2017. . Latest entry: FY2017.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Use of Expedited Approval Programs for Rare DiseasesA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2017First statedAnnual report

    「患者のニーズが最も緊急である希少疾患に焦点を当て、「ファスト・トラック」制度（新薬優先審査制度）と小規模臨床試験制度を活用しつつ、より適切な販売価格でこのような緊急の医療ニーズを充足することを目指します。」

    緊急性の高い希少疾患に焦点を当て、ファスト・トラック制度と小規模臨床試験制度を活用する新薬開発方針を示している。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for GNI Group yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.